NEXUS HEALTH GROUP
PRINCESS STREET GROUP PRACTICE, 2 PRINCESS STREET, LONDON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 10 | 13 | 76.9% | |
| HF 4 | 2011 | 9 | 9 | 100.0% | |
| HF 4 | 2012 | 8 | 11 | 72.7% | |
| HF 4 | 2013 | 11 | 11 | 100.0% | |
| HF004 | 2014 | 13 | 13 | 100.0% | |
| HF004 | 2015 | 15 | 15 | 100.0% | |
| HF004 | 2016 | 18 | 18 | 100.0% | |
| HF004 | 2017 | 108 | 112 | 96.4% | |
| HF004 | 2018 | 122 | 126 | 96.8% | |
| HF004 | 2019 | 108 | 112 | 96.4% | |
| HF004 | 2020 | 126 | 128 | 98.4% | |
| HF006 | 2021 | 246 | 271 | 90.8% | |
| HF006 | 2022 | 253 | 254 | 99.6% | |
| HF006 | 2023 | 275 | 285 | 96.5% |
